|
|
| | Etalocib Basic information |
| Product Name: | Etalocib | | Synonyms: | Etalocib;LY293111;VML 295;2-(3-(3-((5-Ethyl-4'-fluoro-2-hydroxy-[1,1'-biphenyl]-4-yl)oxy)propoxy)-2-propylphenoxy)benzoic acid;Benzoic acid, 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]-;LY293111 Exclusive;YFIZRWPXUYFCSN-UHFFFAOYSA-N;Etalocib(LY293111) | | CAS: | 161172-51-6 | | MF: | C33H33FO6 | | MW: | 544.61 | | EINECS: | | | Product Categories: | | | Mol File: | 161172-51-6.mol |  |
| | Etalocib Chemical Properties |
| Melting point | 68-70 °C(Solv: acetonitrile (75-05-8)) | | Boiling point | 656.8±55.0 °C(Predicted) | | density | 1?+-.0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:98.5(Max Conc. mg/mL);173.85(Max Conc. mM) | | pka | 3.32±0.36(Predicted) |
| | Etalocib Usage And Synthesis |
| Uses | LY293111 is a leukotriene receptor antagonist and protect neurons from the sPLA2-IB-induced neuronal cell death independently of blocking their receptors. | | Uses | Antineoplastic (inhibits formation of 5-LO, LTB4,LTC4, and thromboxane B2(TxB2); activates PPARγ nuclear receptors). | | Definition | ChEBI: LY293111 is an aromatic ether. |
| | Etalocib Preparation Products And Raw materials |
|